Medical implants, like cardiovascular devices, improve the quality of life for countless individuals but may become infected with bacteria like Staphylococcus aureus. Such infections take the form of a biofilm, a structured community of bacterial cells adherent to the surface of a solid substrate. Every biofilm begins with an attractive force or bond between bacterium and substratum. We used atomic force microscopy to probe experimentally forces between a fibronectin-coated surface (i.e., proxy for an implanted cardiac device) and fibronectin-binding receptors on the surface of individual living bacteria from each of 80 clinical isolates of S. aureus. These isolates originated from humans with infected cardiac devices (CDI; n = 26), uninfected cardiac devices (n = 20), and the anterior nares of asymptomatic subjects (n = 34). CDI isolates exhibited a distinct bindingforce signature and had specific single amino acid polymorphisms in fibronectin-binding protein A corresponding to E652D, H782Q, and K786N. In silico molecular dynamics simulations demonstrate that residues D652, Q782, and N786 in fibronectin-binding protein A form extra hydrogen bonds with fibronectin, complementing the higher binding force and energy measured by atomic force microscopy for the CDI isolates. This study is significant, because it links pathogenic bacteria biofilms from the length scale of bonds acting across a nanometer-scale space to the clinical presentation of disease at the human dimension.
T he Gram-positive bacterium Staphylococcus aureus colonizes the anterior nares (1, 2) of 2 billion individuals worldwide (3) . If S. aureus enters the bloodstream, it can cause an infection in the form of a biofilm living on the surface of an implanted medical device. This possibility is particularly important with cardiac devices, for which rates of infection have increased exponentially over the last decade (4) . Because cardiac device infections (CDIs) are difficult or impossible to eradicate with antibiotic therapy alone (5, 6) , standard practice is complete removal of the infected generator and endovascular leads.
The underlying pathogenesis of S. aureus CDI is the ability of the organism to produce a biofilm (Fig. 1A) . During the early stage of infection S. aureus expresses cell-wall proteins that serve to initiate a biofilm by aiding in the initial attachment and colonization of host tissues or devices (7) . These covalently anchored transmembrane proteins are designated "microbial-surface components recognizing adhesive matrix molecules" (MSCRAMMs) (8) because they bind to human proteins such as fibronectin (Fn) or fibrinogen commonly found in the bloodstream (9) . Implanted materials such as endovascular prostheses become coated with these host proteins (10) . Fn is the host protein most commonly encountered on long-term prostheses (10, 11) .
The MSCRAMM Fn-binding protein (FnBP) plays a central role in the pathogenesis of S. aureus infections (12, 13) by facilitating binding of bacteria to host Fn. Recent studies show Fn-binding protein A (FnBPA) from the type-strain of S. aureus binds to human Fn through a tandem β-zipper mechanism (14, 15) . However, little is known about the clinical significance of this binding event. Herein, we probe the binding mechanism between Fn on a substrate (i.e., a proxy for a prosthesis) and Fn-binding protein on S. aureus (Fig. 1B ) through a complementary experimental and theoretical approach that includes (i) atomic force microscopy (AFM) measurements of binding forces on 80 different clinical isolates of S. aureus obtained from humans with or without cardiac device implants; (ii) sequence data for fnbA (the gene for FnBPA) from the same clinical isolates; and (iii) molecular dynamics (MD) simulations of binding reactions between Fn and FnBPA.
Results and Discussion
Binding Forces on Clinical Isolates of S. aureus. The binding forces that initiate a biofilm have been investigated for a handful of typestrains or laboratory-derived strains of S. aureus (e.g., refs. [16] [17] [18] [19] [20] and related species such as Staphylococcus epidermidis (e.g., ref. 21 ). However, no one has examined a large population of clinically derived strains of Staphylococcus that cause disease in humans. For this study, we used 80 different S. aureus isolates from three distinct clinical groupings (Table S1 ): (i) patients with S. aureus bacteremia (i.e., S. aureus in the bloodstream) and confirmed CDI (n = 26); (ii) patients with S. aureus bacteremia and an uninfected cardiac device (CDU; n = 20); and (iii) the nares of healthy subjects living in the same medical referral area (HS; n = 34).
AFM was performed on at least 10 living cells for each isolate, generating >250,000 force curves. Attractive interactions resulted in distinct, nonlinear profiles as the Fn-probe was pulled from contact with a bacterium (Fig. 2A) . This sawtooth-shaped feature was observed when an Fn-tip was used to probe a strain of Lactococcus lactis (a Gram-positive bacterium whose native genome lacks MSCRAMMs) engineered to express only FnBPA or Fnbinding protein B (FnBPB) on its cell wall (20) . Therefore, these signatures likely originate from the mechanical unfolding of proteins, in this case the sequential unraveling of domains within the complex of Fn bound to FnBP on S. aureus (see the worm-like chain model in Fig. 2A) .
Recent NMR and X-ray crystallography studies have revealed 11 domains (∼40 residues each) within FnBPA capable of forming tandem β-zipper interactions with F1 domains in Fn (Fig. 1C) (14, 15) . S. aureus FnBPB, which has sequence homology with FnBPA, has 10 of these Fn-binding repeats (FnBRs) (22) . These NMR and crystallography studies were conducted with small purified or synthetic fragments of Fn and FnBPA (14, 15) . The force measurements presented herein complement that work by probing the binding complex on living S. aureus expressing intact proteins in their native state. Force profiles like those in Fig. 2A show a structurally functional protein-protein binding complex that can be unfolded mechanically with an external force.
The binding activity for each isolate was defined as the frequency of observing a discrete sawtooth-shaped force signature. Fig. 2B shows the distribution of binding-force signatures for bacteria from each of the three clinical sources of S. aureus. The average binding activity of the CDI isolates was significantly greater than that of the CDU and HS populations (P < 0.05). This difference in binding suggests that a microorganism's "force taxonomy" could serve as an indicator of pathogen-related risk for patients. This type of screening could be helpful, given that >80% of health care-associated S. aureus infections come from endogenous sources (23) .
Single Amino Acid Polymorphisms in FnBPA from S. aureus. Why do bacteria from different clinical groups exhibit different bond activity when all measurements were performed on isolates of the same bacterial species expressing the same FnBP? To address this question, the sequence variation in FnBPA was determined by sequencing the portion of fnbA that codes for the 11 FnBRs. We chose to focus on fnbA rather than fnbB because all isolates had fnbA, but only 85% of the CDI isolates possessed the gene for FnBPB (i.e., 15% of the CDI isolates had only fnbA). This distribution is similar to that reported in other studies of clinical isolates, which have found that >70% of isolates have both FnBPA and FnBPB, 20% have only FnBPA, but isolates encoding only FnBPB are rare (∼1%) (24, 25) . Fig. 1C shows the primary sequence of FnBPA from the typestrain S. aureus NCTC 8325 (26) isolates. Three SNPs corresponding to residues E652D, H782Q, and K786N in FnBPA were significantly more common in the CDI isolates (P < 0.01) ( Table 1) . For these three SNPs, the occurrence of multiple (i.e., two or three) polymorphisms in the same S. aureus isolate also was more common for the CDI group (P < 0.01) (Table  S2 ). All three of these polymorphisms are located within regions of FnBPA identified as high-affinity FnBRs (22) . This association between CDI and the presence of the three SNPs was not explained by bacterial ancestry as assessed by multilocus sequence typing (MLST) (Table S3) , by the presence of other MSCRAMM adhesins including bone sialoprotein-binding protein (bbp), clumping factor A (clfA), clumping factor B (clfB), collagenbinding adhesion (cna), elastin-binding protein (ebpS), extracellular fibrinogen-binding protein (efb), polysaccharide intercellular adhesin (icaA), or major histocompatibility analog protein/extracellular adherence protein (map/eap) (Table S4 ), or by the overexpression of fnbA (Fig. S1 ).
Binding Energy on Clinical Isolates of S. aureus. Fig. 2B shows higher binding activity for the CDI isolates. The results in Table 1 reveal nonsynonymous SNPs (positions 652, 782, and 786 in FnBPA) that are significantly more common in the CDI group than in the two other clinical groups. To determine whether there also is a stronger bond for the CDI isolates, the energy (or work) of binding for each force curve was determined by integrating force with respect to distance (Fig. S2 ). S. aureus isolates from the CDI group exhibited stronger binding energy (P < 0.01) ( Fig. 2C and Fig. S3 ). The binding force also was stronger for the CDI group (P < 0.01) (Fig. 2D) Reported are the percentages (and numbers) of isolates from patients with CDI, CDU, and the anterior nares of HS. S. aureus 8325-4 served as the reference strain. The difference between groups was tested for CDI vs. CDU as well as a comparison of the two control groups (CDU vs. HS). All P values were calculated with the χ 2 test. The significance of P values was confirmed with Fisher's Exact test. *One isolate from the healthy subjects had a double-nucleotide polymorphism at position 2099 and 2100 in fnbA (GCA to GTG) resulting in A661V in FnBPA. † P < 0.01. ‡ P < 0.001. § P < 0.05.
these three polymorphisms also was tested with a photometric adhesion assay. This assay showed an increased number of S. aureus cells on Fn-coated substrates for isolates that have polymorphisms E652D, H782Q, and/or K786N in FnBPA (Fig. S4 ). Taken together, these experiments demonstrate a significant relationship between the sequence of FnBPA and the actual activity of this protein in its native state within a living cell.
MD Simulations of Fn Binding to FnBPA. MD simulations were used to determine whether the three SNPs influence the structure of the Fn-FnBPA binding mechanism. MD simulations were performed comparing Fn interactions in the wild-type FnBPA-9 and in FnBPA-9 with SNPs H782Q, and K786N as well as in FnBPA-5 containing either E or D at position 652 ( Fig. 1 B and C) . Fig. 3 shows the final structures of 10-ns MD simulations for both wildtype and variant FnBPA-9 in complex with Fn. The simulations show that Q782 and N786 are able to form well-defined, stable, extra hydrogen bonds with Fns R125 and I106, respectively (see the two dotted lines in Fig. 3 and Movie S1). In the case of H782Q, the hydrogen bond is possible only with Gln (Q), because of its hydrogen-binding acceptor site. The hydrogen bond involves the side chains of FnBPA-9 Q782 and Fn R125. Over the course of the simulation, hydrogen bonds between Gln-782 and Arg-125 were observed 43% of the sampled time. In the case of K786N in FnBPA, both have a donor site, but Lys (K) has a longer chain than Asn (N) and does not fit well in the small cavity. Therefore, the hydrogen bond is predicted between the side chain of FnBPA N786 and the backbone of Fn I106. Over the course of the simulation, hydrogen bonds between Asn-786 and Ile-106 were observed 86% of the sampled time. Although a carboxyl group is largely conserved at position 652 of FnBPA-5, MD simulations of this candidate SNP reveal that D in this sequence is capable of forming a higher number of hydrogen bonds with Fn than E at the same position (average number of hydrogen bonds was 0.75 for D and 0.35 for E; Fig. S5 and Movie S2).
While the contribution of a single hydrogen bond per se may not be sufficient to generate the increased binding energy (27, 28) , each FnBPA molecule in S. aureus has the capacity to bind up to nine molecules of Fn (29, 30) , and each S. aureus bacterium expresses multiple copies of FnBPA on its cell wall. Experimental measurements on biomolecular association have indicated that an individual uncharged hydrogen bond contributes ca. 0.5-1.5 kcal/ mol to binding energy, increasing specificity by two-to 20-fold (31, 32) . These values reach up to 4 kcal/mol if a charged group is involved, increasing specificity by a factor of 1,000. Thus, hydrogen bonds provide specificity as well as indirect stability at proteinprotein interfaces (33, 34) . In addition, unfavorable steric interactions, such as exposed surface area or unpaired charged donors or acceptors, can yield far higher specificity. Therefore, additional hydrogen bonds can lead to a larger protein-protein contact area, resulting in stronger bonds between the molecules (35, 36) . Indeed, X-ray crystallographic measurements have shown that interactions between F1 domains in Fn and FnBRs in FnBPA bury significant amounts of surface area, thereby enhancing the efficiency of this protein-protein interaction (15) .
Binding Forces of Synthetic FnBR-9 Peptides. A final experimental test was performed to determine whether these polymorphisms could be responsible for the increased binding demonstrated by the MD simulations. AFM was used to probe directly the strength of the bond between Fn and synthesized peptides that were identical to the [2] [3] F1 binding motif in FnBR-9, a repeat that contains two of the three key polymorphisms (H782Q and K786N) (Fig. 1C) . Compared with the wild-type sequence, the activity (or frequency) of binding was 15 and 34% higher for peptides with the single and double polymorphisms, respectively ( Table 3 ). The avidity of bonds, as measured by force and energy, also was stronger for the single and double polymorphisms than for the wild-type peptide. Statistically, the double mutant has a greater impact on the binding complex (see P values in Table 3 ). This experimental evidence shows that our identified polymorphisms H782Q and K786N could indeed be responsible for the increased binding observed for S. aureus with this variant FnBPA.
Limitations of the Present Study. The work presented here shows a link between FnBPA in S. aureus and the outcome of bacteremic patients with cardiac device implants. However, other S. aureus adhesins, such as those shown in Table S4 , also could play an important role in the pathogenesis of disease on cardiac devices or other surgical implants. For example, there is a great deal of sequence homology between FnBPA and FnBPB (22) . Although Shinji et al. (25) show that FnBPA is more important for in vitro and in vivo infections by S. aureus, these authors note, "cooperation between FnBPA and FnBPB is indispensable." For the 15% of the CDI isolates that lacked fnbB in our study (Table S4) , every one expressed a variant of FnBPA with at least two of the three polymorphisms (E652D, H782Q, and/or K786N), and 75% of the fnbB-deficient CDI isolates exhibited strong (i.e., higher than the median) binding to Fn as measured by AFM.
The association between the clinical origin of S. aureus (e.g., CDI) and specific SNPs in FnBPA leads to another important, unresolved question. Were these polymorphisms present before CDI, or did they arise as a consequence of it? The latter is conceivable, given that virulence genes like fnbA can undergo rela- Binding energy was determined by integrating the measured force profiles (see Fig. S2 for reference) obtained on isolates from patients with infected (CDI) or uninfected (CDU) cardiovascular implants, as well as nasal carriage isolates from healthy subjects (HS). P = 0.0045 for CDI and CDU isolates (n = 46), two-tailed Fisher's exact test; P = 0.0020, χ 2 test. When HS isolates are included (n = 80), the two-tailed P = 0.0406 for Fisher's exact test, and P = 0.0222 for the χ 2 test. tively rapid molecular evolution, compared with housekeeping genes, in populations of S. aureus (e.g., see ref. 37 ). Because endogenous sources, typically colonies in the nasal mucosa, cause >80% of S. aureus infection (1, 23), the differences in fnbA between the HS and CDI groups ( Table 1 and Table S2 ) could suggest that the polymorphisms arise in the setting of infection.
One the other hand, some isolates from the HS and CDU groups (5-27%) have one or two of the three key SNPs (Table S2 ). These SNPs also are found in a range of MLST backgrounds (Table S3 ). This observation suggests that the population of isolates that are present in the community is responsible for infections and that an infection with an isolate that has these three polymorphisms increases the likelihood that the device itself will become infected. This observation also would mean that individuals colonized with S. aureus isolates lacking the three polymorphisms actually could have a lower risk of serious device-related infection. This important question could be resolved by comparing fnbA sequences from CDI isolates and nasal carriage isolates from the same patients collected before and after infection. Unfortunately, it is not standard practice to collect nasal carriage specimens at the time of implantation or initial presentation of disease. Regardless of the origin, our discovery of an association between specific SNPs and clinical severity of inflection implies that specific polymorphisms in the FnBRs of FnBPA influence the likelihood of CDI in patients with S. aureus bacteremia.
Implanted medical devices improve the lives of countless patients. Ironically, these same devices place some patients at risk for device-associated infections. Although S. aureus is the leading cause of prosthetic valve endocarditis (38) , not all patients with S. aureus in their blood (i.e., bacteremia) develop an infected device. Whether a patient develops an infection probably depends on attributes of both the human host (e.g., physical health) and the bacteria pathogen. This article touches on the pathogen-related risk by demonstrating an important link from the bedside to the bond, i.e., the clinical presentation of disease at the human dimension and the nanometer-scale force that triggers a biofilm. Our experimental measurements and theoretical simulations show that polymorphisms in key binding proteins lead to stronger, more resilient binding mechanisms that select for isolates of S. aureus that form infectious biofilms on cardiovascular devices in humans. Perhaps, additional work will reveal a fundamental force law that can be exploited to prevent S. aureus from forming the initiating bond in the first place.
Materials and Methods
Blind experimental practices were performed to the extent possible. S. aureus isolates were collected from 80 different humans (Table S1 ) and assigned a unique study number. Importantly, we used a rigorous study design to minimize potential for bias. For example, investigators assembling AFM measurements and investigators ascertaining clinical cases and generating fnbA sequence data were fully blinded to the results of the other team. MD simulations were performed by an individual who was unaware of case ascertainment, AFM analyses, or fnbA sequencing. Further details are given in SI Materials and Methods. (39) . CDU isolates (n = 20) were obtained from the bloodstream of patients with uninfected prosthetic devices. A device was defined as uninfected if the patient had no evidence of device infection at the time of the initial blood culture, the cardiac device was not removed, and there was no evidence of recurrent infection 12 wk after the onset of bacteremia (i.e., no S. aureus in the bloodstream) or no evidence of device infection at autopsy. To account for geographic variation of strains, the HS population of S. aureus came from the anterior nares of asymptomatically colonized subjects (n = 34) living in the same medical referral area.
Source of S. aureus
AFM Experiments with Clinical Isolates of S. aureus and Peptides. Each S. aureus isolate was cultured in tryptic soy broth to exponential stage (OD 600 = 0.51 ± 0.01) so that they expressed FnBPA on their exterior surface (7, 20) . Washed cells were deposited onto Fn-coated slides (BD Biosciences). An inverted optical microscope (Axiovert 200M; Zeiss) was used to position a Fn-coated tip (nominal radius 20 nm, measured spring constant 0.1 ± 0.06 nN nm ) over a S. aureus bacterium within the AFM (Veeco Bioscope AFM with Nanoscope IV controller). Forces were measured on live cells immersed in PBS (pH 7.4) according to procedures given in refs. 20 and 40. The tip was pressed against a cell until the cantilever flexed 100 nm. A single approach-retraction cycle took 1-2 s. The vertical travel of the z-piezoelectric scanner was 2.7 μm. Data acquisition was confined to <30 min from harvesting to assure cell viability (40) .
Synthetic peptides (United Biosystems) were sequenced with MS to confirm sequence identity and analyzed with HPLC to ensure >95% purity. Each peptide was linked to an AFM tip through a strong, covalent bond between the gold on the tip and the thiol group of a cysteine engineered at the C terminus of each peptide (41) . AFM measurements were performed in PBS with both commercially available Fn-coated slides (BD-Biosciences) and homemade slides coated with 0.1% Fn-solution. Control experiments were performed with uncoated AFM tips on Fn-coated slides in PBS.
Amino Acid Polymorphisms in FnBPA from Clinical Isolates of S. aureus. Genomic DNA was extracted from S. aureus cultures using the Ultraclean Microbial DNA Isolation Kit (MO BIO). The fnbA gene was amplified by primer fnbA-F and fnbA-R (Table S5) for use as the sequencing template. PCR products then were sequenced in both directions to cover the entire Fn-binding region corresponding to amino acids 512-874 in S. aureus FnBPA. The length of the translated FnBPA was the same in all isolates, 363 residues. Each isolate's sequence was compared with fnbA from reference strain S. aureus NCTC 8325 (UniProt accession number P14738) (26) using the ClustalW and DNASTAR programs. The fnbA sequences reported in this paper have been deposited in GenBank data (accession no. JF809617-JF809662, and JN848717-JN848750). VPQIQGQNKGNQSFEEDTEC 0.68 ± 0.07 P = 0.092 298 ± 26 P < 0.0001**** 1.90 ± 0.58 P = 0.23 3 VPQIQGQNNGNQSFEEDTEC 0.79 ± 0.07 P = 0.002** 352 ± 30 P < 0.0001**** 3.67 ± 0.48 P < 0.0001**** Peptide 1 is identical to the wild-type sequence of 2-3 F1-binding motifs in FnBR-9 (22) . Bold, underlined letters show single or double polymorphisms (Q and N) in the other two peptides. For each peptide, two different peptide-coated tips were used in force measurements. Reported values are the average ± 95% confidence interval. P values were calculated with a t test for 1 vs. 2 and 1 vs. 3. **P < 0.01; ****P < 0.0001. pN, picoNewtons. *A cysteine residue (C) was added to the C terminus so that each peptide could be linked to a gold-coated atomic force microscope tip through the thiol group. † Residues V through E represent the primary sequence of amino acids 778-796 in FnBR-9 of FnBPA from the type-strain S. aureus 8325. 3CAL) and was used as a starting point for the simulations of H782Q and/or K786N. The replacement of sequence FnBPA-5 and -9 is a reasonable change, given that FnBPA has multiple high-affinity binding repeats for the same Fn scaffold and protein structure is more evolutionarily conserved than sequence (42 (15) .
MD Simulations of Fn
Residue replacement was carried out with DeepView software (43) . pK a calculations were performed with PROPKA (44) to evaluate protonation states of each titratable residue. The systems were solvated in explicit water using the simple point charge (SPC) model (45); counter ions were added as necessary to ensure system neutrality, and geometry was optimized using 1,000 steps of the steepest descent algorithm. For each system, a 10-ns MD simulation was performed at the isothermal isobaric (NPT; N, moles; P, pressure; T, temperature) ensemble using the double-precision parallel version of the GROMACS 4 (46) . Temperature was kept at 300 K using the Nosé-Hoover thermostat (47) , and pressure was maintained at 1 bar via the Parrinello-Rahman method (48) . Periodic boundary conditions were used with a 1.4-nm cutoff for nonbonded interactions. Long-range electrostatic corrections were taken into account by the particle mesh Ewald method (49 and uninfected cardiac device (CDU) groups came from the S. aureus bacteremia (SAB) registry at Duke University Medical Center. The SAB registry has prospectively collected clinical data (initial admission and 12-wk follow-up) and the corresponding S. aureus isolate from each consenting adult inpatient with pure SAB at Duke University since 1994 (n > 2,000). Nasal carriage isolates were obtained from the anterior nares of healthy subjects (HS) living in the same geographic area as individuals infected with the disease-causing isolates. S. aureus isolates were cultured under conditions that promote the expression of fibronectin (Fn)-binding protein A (FnBPA) on the exterior surface of the cells (1, 2) . Briefly, each growth culture was started from a cryogenically preserved sample. Each isolate was cultured to early exponential stage (OD 600 = 0.51 ± 0.01; OD 550 = 0.54 ± 0.01) at 37°C in tryptic soy broth containing 0.25% dextrose. Growth curves were determined for 25 randomly selected clinical isolates to ensure similar growth characteristics for all isolates (i.e., the absorbance at early exponential stage). Approximately 1 mL of cell suspension was harvested using a centrifuge (5,000 × g for 3 min). Cells then were washed three times in saline solution. A small volume of washed cells (80 μL) was dropped onto an Fn-coated coverslip (BD Biosciences) and allowed to sit (without drying) for ∼5 min. Each sample was rinsed with PBS (pH 7.4) and placed in the atomic force microscope where force measurements commenced immediately.
The main text presents force measurements on individual cells from each of the 80 different clinical isolates described above. A Veeco/Digital Instruments Bioscope atomic force microscope and Nanoscope IV controller with an attached inverted microscope (Axiovert 200M; Zeiss) were used in these studies. The inverted microscope was used to locate and position the tip of the atomic force microscope tip over S. aureus cells. Silicon nitride probes [nominal tip radius 20 nm, measured spring constant 0.1 ± 0.06 nN nm −1 (3)] were used in these experiments. These probes were coated with Fn according to published protocol (2, 4) . Some cantilevers were coated with BSA to characterize nonspecific interactions (5) .
Forces were measured on cells immersed in PBS solution according to methods described in refs. 2, 4, and 6. Briefly, an Fncoated probe was brought into contact with a bacterium and was pushed against the cell wall until the cantilever flexed 100 nm. The probe then was retracted away from the bacterium until the probe was separated completely from the cell. The vertical travel distance of the z-piezoelectric scanner was 2.7 μm. This process resulted in an approach force curve as well as a retraction force curve. A single approach-retraction cycle took 1-2 s (i.e., 0.5-1.0 Hz scan rate). Data acquisition was confined to ≤30 min from harvesting to assure cell viability (4) .
Atomic force microscopy also was performed on an additional 16 isolates from the CDI (n = 9), CDU (n = 1), and HS (n = 6) groups. However, these isolates were excluded from the article because we did not have fnbA sequence data or multilocus sequence typing (MLST) information for these 16 isolates. It is important to note that our conclusions are the same when we include these 16 isolates. Specifically, the binding force and energy are both statistically stronger for the CDI isolates (P < 0.01) when n = 96 isolates (Fig. S3) . Residue replacement was carried out using the DeepView software (8) . A side chain rotational search was performed to avoid steric hindrance upon each replacement. His (H) and Lys (K) are both polar residues. Although Lys is positively charged at physiological pH, His can assume either a neutral or positive charge depending on its chemical environment. Gln (Q) and Asn (N) are both polar and generally uncharged amino acids. pK a calculations were performed using the PROPKA program (9) to evaluate the protonation states of each titratable residue in the complex. No unusual protonation states were predicted. All histidines were predicted to be neutral and were treated as such.
The systems were solvated in explicit water using the simple point charge (SPC) water model (10), counter ions were added as necessary to ensure system neutrality, and geometry was optimized using 1,000 steps of the steepest descent algorithm. For each system, a 10-ns molecular dynamics simulation was performed. The simulations were conducted at the isothermal isobaric (NPT; N, moles; P, pressure; T, temperature) ensemble. Temperature was kept at 300 K using the Nosé-Hoover thermostat (11) with separate 1-ps relaxation times for solute and solvent. Pressure was maintained at 1 bar using the Parrinello-Rahman method (12) with the isothermal compressibility of 4.5 × 10 −5 (kJ mol −1 nm
and relaxation time of 1 ps. A time step of 2 fs was used to integrate the equations of motion using the leapfrog algorithm (13) . Periodic boundary conditions were used with a 1.4-nm cutoff for the nonbonded interactions. Long-range electrostatic corrections were taken into account by using the particle mesh Ewald method (14) . The LINCS algorithm (15) was applied to all chemical bond lengths involving hydrogen atoms. Positional restraints were used on the C α atoms using a force constant of 1,000 kJ mol −1 to avoid artificial repulsion between Fn and FnBPA caused by sequence replacement/molecular modeling and because the X-ray coordinates comprise only part of the full complex. This procedure ensured proper structural relaxation of the modeled side chains of receptor and ligand. Structural data were collected and analyzed at 500-fs intervals. All simulations were performed using the doubleprecision parallel version of the GROMACS 4 (16) in conjunction with the 53A6 parameter set of the GROMOS force field (17) (18) (19) .
Atomic Force Microscopy Experiments on Peptides. Three synthetic peptides (>95% purity) were used in these experiments: (i) a 20-mer peptide whose sequence was identical to the native sequence of amino acids within S. aureus FnBR-9; (ii) a peptide with a single-residue change to mimic the polymorphism H782Q in FnBPA; (iii) a peptide with two residue changes to mimic H782Q and K786N in FnBPA. Gold-coated atomic force microscope tips were incubated in a solution of each peptide (100 μg L −1 in PBS) for 2 h. This incubation allowed direct linkage of each peptide to the atomic force microscope tip through a strong, covalent bond be-tween the gold on the tip and the thiol group of the cysteine engineered at the C terminus of each peptide (20, 21) . Two different peptide-functionalized tips were created for each of the three peptides. Measurements were performed in PBS on Fn-coated slides. Control experiments were performed with uncoated atomic force microscope tips on Fn-coated slides in PBS.
MLST and PCR of Adhesin Genes in the S. aureus Isolates. S. aureus genomic DNA was extracted using an ultraclean microbial DNA kit (MO BIO) in accordance with the manufacturer's instructions. MLST was performed as described previously (22) . PCR assays were used to screen the S. aureus genome for 10 adhesion and/or biofilm-related genes, including bone sialoprotein-binding protein (bbp), clumping factor A (clfA), clumping factor B (clfB), collagenbinding adhesion (cna), elastin-binding protein (ebpS), extracellular fibrinogen-binding protein (efb), polysaccharide intercellular adhesin (icaA), and major histocompatibility analog protein/extracellular adherence protein (map/eap). The primers and conditions used to amplify the genes of interest are given in Table S5 (23).
Quantitative Real-Time RT-PCR Analysis of Expression of fnbA. S. aureus isolates were cultured to midexponential phase in tryptic soy broth at 37°C. The cells were pelleted by centrifugation, resuspended in RLT buffer (Qiagen), and total RNA was isolated using the RNeasy kit (Qiagen) and Mini-BeadbeaterTM (Bio Spec Products) as described previously (24) . Contaminating DNA was digested with DNase I (Ambion) for 1 h at 37°, and 2 μg of RNA was converted to cDNA using the iScript One-Step RT-PCR kit (BioRad) according to the manufacturer's instructions. The reaction without reverse transcriptase enzyme was used as a control. Real-time RT-PCR reactions contained 2 μL cDNA or diluted no-RT control, 1 pmol forward and reverse primers, 8.5 μL nucleasefree deionized water, and 12.5 μL IQ SYBR Green Supermix (BioRad). Real-time RT-PCR was performed using an iCycler Real-Time PCR Detection system (BioRad) under the following conditions: 95°C for 5 min, 40 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 30 s. The normalized amount of transcript for each gene was expressed as the n-fold difference relative to the control gene (2 ΔCT , where ΔCT represents the difference in threshold cycle between the target gene and the 16S rRNA gene). Samples were performed in triplicate, and each experiment was repeated three times to ensure reproducibility.
Adhesion Assay with 96-Well Plates. The adhesion assay with 96-well plates was modified from Peacock et al. (25) . Briefly, 96-well plates were coated with 0.02% sodium carbonate (pH 9.6) containing Fn (10 μg/μL) overnight at 4°C. The plates were washed with PBS, blocked with 2% BSA solution for 1 h at 37°C, and then washed again. Bacteria were collected from broth cultures, adjusted to optical density 1.0 at 600 nm (corresponding to 10 7 cells/mL), and incubated in the wells for 2 h at 37°C. After washing with PBS, bacteria were fixed with 25% formaldehyde for 10 min, followed by the addition of 0.5% crystal violet for 1 min, and finally 100 μL DMSO. Absorbance was measured at 620 nm using a Multiskan Ascent plate reader (MTX Lab Systems). Absorbance values were expressed as a percentage of that recorded for S. aureus 8325-4 on the same plate. . Two retraction profiles measured when an Fn-coated tip was pulled from contact with a S. aureus bacterium expressing Fn-binding proteins. The work or energy of binding, in aJ (nN × nm), was determined by integrating each retraction force profile. Each rupture event terminates with a "jump from contact" line whose slope is equal to the cantilever spring constant. This feature occurs when the cantilever spring constant exceeds the actual force gradient between the tip and sample, causing the tip to snap free of the sample. A nearly vertical jump-from-contact line could be obtained with very stiff cantilevers, but such levers lack the sensitivity to measure small forces like those for biological samples. The area of integration may overestimate the work of binding because it incorporates the jump-from-contact event. However, any bias is the same for all S. aureus isolates, because all cantilevers used in this study were of the same type (long, narrow) and from the same wafer. Fig. S3 . Box and whisker plots of (A) frequency of observing a sawtooth force signature from CDI (n = 35), CDU (n = 21), and HS (n = 40) groups and (B) binding energy for S. aureus isolates from CDI (n = 35) and CDU (n = 21) groups. Whisker ends represent ninth and 91st percentiles. Data for 80 of these isolates are provided in the main text. The additional 16 isolates were excluded from the article because these isolates were analyzed only with atomic force microscopy. For these 16, we do not have the other data (e.g., fnbA sequence, MLST data, and/or presence/absence of MSCRAMM adhesin genes) that we obtained for the 80 isolates presented in the main text. Clonal relationships were determined by MLST analyses (1), and diversity was measured as the Simpson's Index of Diversity (2) . Reported are the percentages (and number) of isolates for each major clonal complex (CC).
The difference between groups was tested using a Fisher's exact test for CDI vs. CDU and for comparison of the two control groups (i.e., CDU vs. HS). *Calculated with Fisher's exact test.
† MLST could not be performed successfully on two isolates from HS group. ‡ Other category includes CCs with too few observations to test separately and isolates without an identified CC.
For CDI these isolates included one CC1 isolate, one CC8 isolate, two CC20 isolates, and 10 isolates without identified CCs. For CDU these isolates included one CC1 isolate, one CC8 isolate, two CC45 isolates, one CC97 isolate, and five isolates without identified CCs. For HS these isolates included three CC59 isolates and 20 isolates without identified CCs. Reported are the percentage (and number) of isolates with a particular adhesin gene from patients with infected (CDI; n = 26) or uninfected (CDU; n = 20) cardiac devices. Note the percent occurrence for the two Fn-binding proteins (fnbA and fnbB). All isolates possess fnbA. Although 100% of CDU isolates have fnbB, only 85% of CDI possess this adhesin gene. *The primers and conditions used to amplify these 10 genes are described in ref. 1 .
† Calculated with the χ 2 test. Forward  fnbA-F  5′-CCGAACAATATAGACTTGCATTTATT-3′  fnbA-F1  5′-GAACACAAATGGTAGGACATCCAGAGCAAC-3′  fnbA-F2  5′-CAATAGAAGAAACGGATTCATCAGCTATTG-3′  fnbA-F3  5′-CTGGTTTAGGAACTGAAAATGGTCACG-3′  fnbA-F4 5′-CAGTCATTCGAGGAAGATACAGAAAAAGAC-3′ Reverse fnbA-R 5′-CATCAGACATAAACCAATGAAGCAATCAG-3′ fnbA-R1 5′-CTTCATATTCAACAACATCAGCGTGATG-3′ fnbA-R2 5′-CCCGTGACCATTTTCAGTTCCTAAACC-3′ fnbA-R3 5′-GTTGTATCTTCAATCGTTTGTTGACCTTC-3′ fnbA-R4 5′-CTTTACCTTGTTCCACTGGTTTAGAAGG-3′
Movie S1. The movie shows the last 5 ns of the simulations for the Fn-FnBPA9 complexes. Fn (yellow) and FnBPA9 (red) are displayed in the cartoon, where the arrows represent β-strands. The side chains of the pairs Q782/R125 and N786/I106 in the double SNPs are shown in the Corey-Pauling-Koltun (CPK) model (carbon, cyan; oxygen, red; nitrogen, blue; hydrogen, white). The side chain of the corresponding pairs in the FnBPA9 wild-type (H782/R125 and K786/I106) is shown in the stick model (carbon, gray; oxygen, red; nitrogen, blue; hydrogen was omitted for clarity). As can be seen from the relative distance between the pairs Q782/R125 and N786/I106 in the double-SNP sequence, an electrostatic interaction (hydrogen bond) is formed. This interaction is clearly absent in the Fn-FnBPA9 wild-type complex. This movie was created with VMD 1.8 software (Visual Molecular Dynamics) (1).
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